U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C5H13N2O4P
Molecular Weight 196.1415
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALAFOSFALIN

SMILES

C[C@H](N)C(=O)N[C@@H](C)P(O)(O)=O

InChI

InChIKey=BHAYDBSYOBONRV-IUYQGCFVSA-N
InChI=1S/C5H13N2O4P/c1-3(6)5(8)7-4(2)12(9,10)11/h3-4H,6H2,1-2H3,(H,7,8)(H2,9,10,11)/t3-,4+/m0/s1

HIDE SMILES / InChI

Molecular Formula C5H13N2O4P
Molecular Weight 196.1415
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Alafosfalin is a phosphonodipeptide with significant activity as an antibacterial agent and as a potentiator of beta-lactam antibiotics. Alafosfalin shows good activity both in vitro and in vivo, particularly against Enterobacteriaceae. The compound acts by interfering with bacterial cell wall biosynthesis and also potentiates the activity of beta-lactam antibiotics. Alafosfalin was found to be highly active against Escherichia coli and moderately active against Serratia, Klebsiella, Enterobacter, and Citrobacter, but less active against gram-positive organisms than were beta-lactams such as cephazolin or ampicillin and inactive against indole-positive Proteus, Pseudomonas, and Acinetobacter.

Approval Year

PubMed

PubMed

TitleDatePubMed
Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with beta-lactams.
1979 Oct
Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans.
1980 Jun
Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria.
1985 Jun
Patents

Sample Use Guides

Studies in humans showed that oral doses of 50 to 2,500 mg were well absorbed, but some metabolic hydrolysis occurred before the drug reached the general circulation. Oral bioavailability was approximately 50% and was largely independent of dose.
Route of Administration: Oral
In Vitro Use Guide
E.coli were the most susceptible to alafosfalin among all species, among 144 isolates, 93 and 86% of the strains were inhibited by 12.5 and 1.56 ug/ml, respectively, whereas the MIC50 was 0.39 ug/ml.
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:28:34 GMT 2023
Edited
by admin
on Sat Dec 16 17:28:34 GMT 2023
Record UNII
0M8OM373BS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALAFOSFALIN
INN   MART.   MI  
INN  
Official Name English
((1R)-1-((2S)-2-AMINOPROPIONAMIDO)ETHYL)PHOSPHONIC ACID
Systematic Name English
ALAFOSFALIN [MI]
Common Name English
ALAPHOSPHIN
Common Name English
alafosfalin [INN]
Common Name English
P-((1R)-1-(((2S)-2-AMINO-1-OXOPROPYL)AMINO)ETHYL)PHOSPHONIC ACID
Systematic Name English
ALAFOSFALIN [MART.]
Common Name English
RO-3-7008
Code English
Classification Tree Code System Code
NCI_THESAURUS C258
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
Code System Code Type Description
MESH
C006437
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
SMS_ID
100000087710
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
CAS
60668-24-8
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
NCI_THESAURUS
C74137
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
EPA CompTox
DTXSID6046393
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
WIKIPEDIA
Alafosfalin
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
FDA UNII
0M8OM373BS
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
ECHA (EC/EINECS)
262-362-8
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
EVMPD
SUB05289MIG
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
ChEMBL
CHEMBL334756
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
MERCK INDEX
m1465
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY Merck Index
INN
4540
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
PUBCHEM
71957
Created by admin on Sat Dec 16 17:28:34 GMT 2023 , Edited by admin on Sat Dec 16 17:28:34 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY